S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
Costco vs Amazon: an end of the year showdown
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Next-Generation Fighter Jets?!? (Must See) (Ad)pixel
Closing prices for crude oil, gold and other commodities
Discount Retailers Could Make Good Bargain Stocks
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
How major US stock indexes fared Friday 12/9/2022
K-pop star among 8 to join Japan tycoon Maezawa's moon trip
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
Costco vs Amazon: an end of the year showdown
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Next-Generation Fighter Jets?!? (Must See) (Ad)pixel
Closing prices for crude oil, gold and other commodities
Discount Retailers Could Make Good Bargain Stocks
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
How major US stock indexes fared Friday 12/9/2022
K-pop star among 8 to join Japan tycoon Maezawa's moon trip
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
Costco vs Amazon: an end of the year showdown
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Next-Generation Fighter Jets?!? (Must See) (Ad)pixel
Closing prices for crude oil, gold and other commodities
Discount Retailers Could Make Good Bargain Stocks
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
How major US stock indexes fared Friday 12/9/2022
K-pop star among 8 to join Japan tycoon Maezawa's moon trip
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
Costco vs Amazon: an end of the year showdown
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Next-Generation Fighter Jets?!? (Must See) (Ad)pixel
Closing prices for crude oil, gold and other commodities
Discount Retailers Could Make Good Bargain Stocks
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
How major US stock indexes fared Friday 12/9/2022
K-pop star among 8 to join Japan tycoon Maezawa's moon trip
NASDAQ:ANGO

AngioDynamics - ANGO Stock Forecast, Price & News

$12.25
-0.12 (-0.97%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$12.25
$12.50
50-Day Range
$12.06
$21.55
52-Week Range
$11.71
$30.00
Volume
298,809 shs
Average Volume
323,041 shs
Market Capitalization
$479.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.00

AngioDynamics MarketRank™ Forecast

Analyst Rating
Strong Buy
4.00 Rating Score
Upside/​Downside
144.9% Upside
$30.00 Price Target
Short Interest
Healthy
2.54% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.84
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Acquiring Shares
$164,967 Bought Last Quarter
Proj. Earnings Growth
1,300.00%
From $0.01 to $0.14 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Medical Sector

230th out of 1,034 stocks

Surgical & Medical Instruments Industry

27th out of 101 stocks

ANGO stock logo

About AngioDynamics (NASDAQ:ANGO) Stock

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

Receive ANGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter.

ANGO Stock News Headlines

Here's Why This Hidden Growth Stock Is a Buy
AngioDynamics (NASDAQ:ANGO) Issues FY 2023 Earnings Guidance
AngioDynamics (ANGO) Q1 Earnings, Revenues Lag Estimates
See More Headlines
Receive ANGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter.

ANGO Company Calendar

Last Earnings
10/06/2022
Today
12/09/2022
Next Earnings (Estimated)
1/05/2023
Fiscal Year End
5/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:ANGO
CUSIP
03475V10
Employees
800
Year Founded
1988

Price Target and Rating

Average Stock Price Forecast
$30.00
High Stock Price Forecast
$35.00
Low Stock Price Forecast
$25.00
Forecasted Upside/Downside
+144.9%
Consensus Rating
Strong Buy
Rating Score (0-4)
4.00
Research Coverage
1 Analysts

Profitability

Net Income
$-26,550,000.00
Pretax Margin
-10.97%

Debt

Sales & Book Value

Annual Sales
$316.22 million
Cash Flow
$0.76 per share
Book Value
$10.96 per share

Miscellaneous

Free Float
37,192,000
Market Cap
$479.07 million
Optionable
Optionable
Beta
0.70

Social Links


Key Executives

  • Mr. James C. ClemmerMr. James C. Clemmer (Age 58)
    CEO, Pres & Director
    Comp: $1.51M
  • Mr. Stephen A. TrowbridgeMr. Stephen A. Trowbridge (Age 48)
    Exec. VP & CFO
    Comp: $709.57k
  • Mr. David D. HelselMr. David D. Helsel (Age 58)
    Sr. VP of Global Operations and R&D
    Comp: $573.85k
  • Mr. Chad T. Campbell (Age 51)
    Sr. VP & GM of Vascular Access Global Bus. Unit
    Comp: $544.19k
  • Ms. Laura Piccinini (Age 52)
    Sr. VP & GM of International
    Comp: $634.52k
  • Mr. Richard C. Rosenzweig (Age 55)
    Sr. VP, Gen. Counsel & Company Sec.
  • Mr. Benjamin H. Davis (Age 58)
    Sr. VP of Bus. Devel.
  • Ms. Marna I. Bronfen-Moore (Age 55)
    Sr. VP of HR
  • Mr. Warren G. Nighan (Age 53)
    Sr. VP of Quality & Regulatory Affairs
  • Ms. Kim L. Seabury (Age 55)
    Sr. VP of Information Technology













ANGO Stock - Frequently Asked Questions

Should I buy or sell AngioDynamics stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AngioDynamics in the last year. There are currently 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "strong buy" ANGO shares.
View ANGO analyst ratings
or view top-rated stocks.

What is AngioDynamics' stock price forecast for 2023?

1 equities research analysts have issued twelve-month price targets for AngioDynamics' shares. Their ANGO share price forecasts range from $25.00 to $35.00. On average, they anticipate the company's share price to reach $30.00 in the next year. This suggests a possible upside of 144.9% from the stock's current price.
View analysts price targets for ANGO
or view top-rated stocks among Wall Street analysts.

How have ANGO shares performed in 2022?

AngioDynamics' stock was trading at $27.58 at the beginning of 2022. Since then, ANGO shares have decreased by 55.6% and is now trading at $12.25.
View the best growth stocks for 2022 here
.

When is AngioDynamics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, January 5th 2023.
View our ANGO earnings forecast
.

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) announced its quarterly earnings data on Thursday, October, 6th. The medical instruments supplier reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.04. The medical instruments supplier earned $81.50 million during the quarter, compared to analysts' expectations of $83.43 million. AngioDynamics had a negative trailing twelve-month return on equity of 0.42% and a negative net margin of 10.16%. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the business earned ($0.02) EPS.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics updated its FY 2023 earnings guidance on Thursday, October, 27th. The company provided earnings per share (EPS) guidance of $0.01-$0.06 for the period, compared to the consensus earnings per share estimate of $0.02. The company issued revenue guidance of $342.00 million-$348.00 million, compared to the consensus revenue estimate of $344.21 million.

What is James C. Clemmer's approval rating as AngioDynamics' CEO?

34 employees have rated AngioDynamics Chief Executive Officer James C. Clemmer on Glassdoor.com. James C. Clemmer has an approval rating of 50% among the company's employees. This puts James C. Clemmer in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 47.0% of employees surveyed would recommend working at AngioDynamics to a friend.

What other stocks do shareholders of AngioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AngioDynamics investors own include General Electric (GE), Intel (INTC), Oasis Petroleum (OAS), Advanced Micro Devices (AMD), Freeport-McMoRan (FCX), Amicus Therapeutics (FOLD), Rigel Pharmaceuticals (RIGL), Accuray (ARAY), Celldex Therapeutics (CLDX) and Chimerix (CMRX).

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

Who are AngioDynamics' major shareholders?

AngioDynamics' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.39%), Victory Capital Management Inc. (7.40%), Dimensional Fund Advisors LP (6.82%), Vanguard Group Inc. (6.62%), State Street Corp (3.85%) and Systematic Financial Management LP (2.70%). Insiders that own company stock include Chad Thomas Campbell, Dave Helsel, James C Clemmer, James C Clemmer, Scott Centea, Stephen A Trowbridge and Wesley Johnson.
View institutional ownership trends
.

How do I buy shares of AngioDynamics?

Shares of ANGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AngioDynamics' stock price today?

One share of ANGO stock can currently be purchased for approximately $12.25.

How much money does AngioDynamics make?

AngioDynamics (NASDAQ:ANGO) has a market capitalization of $479.07 million and generates $316.22 million in revenue each year. The medical instruments supplier earns $-26,550,000.00 in net income (profit) each year or ($0.83) on an earnings per share basis.

How many employees does AngioDynamics have?

The company employs 800 workers across the globe.

Does AngioDynamics have any subsidiaries?
The following companies are subsidiares of AngioDynamics: AngioDynamics Canada Inc., AngioDynamics France SARL, AngioDynamics Medical Brasil Participacoes Ltda., AngioDynamics Netherlands B. V., AngioDynamics UK Limited, AngioDynamics VA LLC, Clinical Devices, Eximo Medical Ltd., FlowMedica, NM Holding Company Inc., Navilyst Medical Holdings Inc., Navilyst Medical Inc., Oncovionic, RITA Medical Systems, RITA Medical Systems LLC, RadiaDyne LLC, and Vortex Medical.
Read More
How can I contact AngioDynamics?

AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The official website for the company is www.angiodynamics.com. The medical instruments supplier can be reached via phone at (518) 795-1400, via email at mpolyviou@evcgroup.com, or via fax at 518-795-1401.

This page (NASDAQ:ANGO) was last updated on 12/10/2022 by MarketBeat.com Staff